227 related articles for article (PubMed ID: 32334459)
21. Salivary L-fucose as a biomarker for oral potentially malignant disorders and oral cancer.
Sharma M; Sharma E; Prabhu V; Pai VR; D'souza JM; Harish S; Jose M
J Cancer Res Ther; 2020; 16(3):546-550. PubMed ID: 32719265
[TBL] [Abstract][Full Text] [Related]
22. Role of salivary biomarkers in early detection of oral squamous cell carcinoma.
Awasthi N
Indian J Pathol Microbiol; 2017; 60(4):464-468. PubMed ID: 29323056
[TBL] [Abstract][Full Text] [Related]
23. Salivary MMP-9 as a Biomarker for the Diagnosis of Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
Smriti K; Ray M; Chatterjee T; Shenoy RP; Gadicherla S; Pentapati KC; Rustaqi N
Asian Pac J Cancer Prev; 2020 Jan; 21(1):233-238. PubMed ID: 31983189
[TBL] [Abstract][Full Text] [Related]
24. Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: diagnostic value and free radical mechanism of action.
Kaur J; Politis C; Jacobs R
Clin Oral Investig; 2016 Mar; 20(2):315-9. PubMed ID: 26077895
[TBL] [Abstract][Full Text] [Related]
25. Altered serum and salivary C-reactive protein levels in patients with oral premalignant lesions and oral squamous cell carcinoma.
Metgud R; Bajaj S
Biotech Histochem; 2016; 91(2):96-101. PubMed ID: 26529498
[TBL] [Abstract][Full Text] [Related]
26. Assessment of brush biopsy findings and salivary LDH levels in oral mucosal lesions of tobacco users.
Davidson SP; Kumar S; Somasundaram E; Jaishankar S
Indian J Dent Res; 2023; 34(2):191-195. PubMed ID: 37787211
[TBL] [Abstract][Full Text] [Related]
27. Serum and salivary levels of albumin as diagnostic tools for oral pre-malignancy and oral malignancy.
Metgud R; Patel S
Biotech Histochem; 2014 Jan; 89(1):8-13. PubMed ID: 23738795
[TBL] [Abstract][Full Text] [Related]
28. Study of the Role of Salivary Lactate Dehydrogenase in Habitual Tobacco Chewers, Oral Submucous Fibrosis and Oral Cancer as a Biomarker.
Mantri T; Thete SG; Male V; Yadav R; Grover I; Adsure GR; Kulkarni D
J Contemp Dent Pract; 2019 Aug; 20(8):970-973. PubMed ID: 31797856
[TBL] [Abstract][Full Text] [Related]
29. Role of Salivary Biomarkers in Oral Cancer Detection.
Khurshid Z; Zafar MS; Khan RS; Najeeb S; Slowey PD; Rehman IU
Adv Clin Chem; 2018; 86():23-70. PubMed ID: 30144841
[TBL] [Abstract][Full Text] [Related]
30. Relevance of serum and salivary sialic acid in oral cancer diagnostics.
Guruaribam VD; Sarumathi T
J Cancer Res Ther; 2020; 16(3):401-404. PubMed ID: 32719243
[TBL] [Abstract][Full Text] [Related]
31. Status of trace elements in saliva of oral precancer and oral cancer patients.
Shetty SR; Babu S; Kumari S; Shetty P; Hegde S; Karikal A
J Cancer Res Ther; 2015; 11(1):146-9. PubMed ID: 25879353
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological Evaluation of Tobacco-related Oral Mucosal Lesions.
Gabhane MH; Hemagiriyappa MS; Sharma VJ; Pardeshi KV; Rai BA; Nahar P
J Contemp Dent Pract; 2022 Apr; 23(4):399-404. PubMed ID: 35945832
[TBL] [Abstract][Full Text] [Related]
33. Can quantifying free-circulating DNA be a diagnostic and prognostic marker in oral epithelial dysplasia and oral squamous cell carcinoma?
Shukla D; Kale AD; Hallikerimath S; Yerramalla V; Subbiah V
J Oral Maxillofac Surg; 2013 Feb; 71(2):414-8. PubMed ID: 22749518
[TBL] [Abstract][Full Text] [Related]
34. Correlation of Cyfra 21-1 levels in saliva and serum with CK19 mRNA expression in oral squamous cell carcinoma.
Malhotra R; Urs AB; Chakravarti A; Kumar S; Gupta VK; Mahajan B
Tumour Biol; 2016 Jul; 37(7):9263-71. PubMed ID: 26779624
[TBL] [Abstract][Full Text] [Related]
35. The predictive value of alkaline phosphatase and lactate dehydrogenase for overall survival in patients with esophageal squamous cell carcinoma.
Wei XL; Zhang DS; He MM; Jin Y; Wang DS; Zhou YX; Bai L; Li ZZ; Luo HY; Wang FH; Xu RH
Tumour Biol; 2016 Feb; 37(2):1879-87. PubMed ID: 26323257
[TBL] [Abstract][Full Text] [Related]
36. Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions.
Ghallab NA; Shaker OG
Clin Oral Investig; 2017 Apr; 21(3):937-947. PubMed ID: 27161218
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic evaluation of lesions associated with tobacco usage.
Samatha Y; Sankar AJ; Ganapathy KS; Srinivas K; Ankineedu D; Choudary AL
J Contemp Dent Pract; 2014 Jul; 15(4):466-72. PubMed ID: 25576115
[TBL] [Abstract][Full Text] [Related]
38. Salivary Her2/neu Levels in Differentiation of Oral Premalignant Disorders and Oral Squamous Cell Carcinomas.
Varun C; Dineshkumar T; Jayant VS; Rameshkumar A; Rajkumar K; Rajashree P; Mathew J; Arunvignesh RK
Asian Pac J Cancer Prev; 2015; 16(14):5773-7. PubMed ID: 26320450
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Salivary and Serum Soluble CD44 Levels between Patients with Oral SCC and Healthy Controls.
Seyedmajidi S; Seyedmajidi M; Foroughi R; Zahedpasha A; Zolfaghari Saravi Z; Pourbagher R; Bijani A; Motallebnejad M; Monfared Shabestani A; Mostafazadeh A
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3059-3063. PubMed ID: 30485941
[TBL] [Abstract][Full Text] [Related]
40. Assessment of lactate dehydrogenase enzyme levels in saliva and serum of oral submucous fibrosis and leukoplakia patients.
Panda A; Behura SS; Bhuyan L; Dash KC; Kumar V; Mukherjee S
J Oral Maxillofac Pathol; 2020; 24(1):183. PubMed ID: 32508472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]